Nailbiter2 wrote: I'm not comparing Stage to Exact Sciences.
Just trying to make sense of the last two releases.
You don't extend warrants for a year
then announce a reverse split at a special meeting.
You don't RS after securing financing.
My point is, this is poop in a box's MO.
They know poop is out and blood is in.
They are trying to achieve this by researching with the Mayo clinic
to come up with exactly what we have.
They have purchased independent labs and
hugely expanded their own lab facility.
They buy other techs to phase the poop tests out.
It might not be EXAS, it could be somebody else.
I could be all green behind the ears too.
We'll know by Jan 23rd.
Just the scenario that makes most sense at the moment.
One hat would crush Grail to dust.
Don't be puttin' in the rough Bud.
TrippinAgain01 wrote: First EXAS sucks, now the pumping patriol are actually trying to compare little bitty SZLS to them. Classic. EXAS and SZLS are total opposites. EXAS mergers were actually meaningful. Since SZLS aquired CARE and launched "Aristotle", revenue has been decreasing lol, how is this possible?
